Epstein-Barr virus with heterogeneous DNA disrupts latency - PubMed (original) (raw)
Epstein-Barr virus with heterogeneous DNA disrupts latency
G Miller et al. J Virol. 1984 Apr.
Abstract
By cloning the HR-1 Burkitt lymphoma line, we previously uncovered two distinct biological variants of nontransforming Epstein-Barr virus (EBV). The most commonly cloned variant has a low rate of spontaneous viral synthesis and is unable to induce early antigen in Raji cells (EAI-). A rare variant spontaneously releases virus which is capable of inducing early antigen in Raji cells (EAI+). Since EAI- virus lacks heterogeneous DNA (het-) and EAI+ virus contains heterogeneous DNA (het+), we suggested that spontaneous viral synthesis and induction of early antigen are biological properties which correlate with the presence of het sequences. The present experiments provide three new lines of experimental evidence in favor of this hypothesis. (i) Revertant subclones of the EAI+ het+ variant which have lost the het DNA concomitantly lost EAI ability. Thus, het DNA is not stably associated with the cells as are the episomes. (ii) het DNA was acquired by two het- subclones of the HR-1 line after superinfection with EAI+ virus. After superinfection, these clones synthesized EAI+ het+ virus. Thus, het DNA may be maintained in the HR-1 line by cell-to-cell spread. (iii) Virus with het DNA activated full expression of endogenous latent EBV of the transforming phenotype in a line of immortalized neonatal lymphocytes designated X50-7. By use of restriction endonuclease polymorphisms unique to both the superinfecting and endogenous genomes, we show that the genome of the activated virus resembles that of the virus which was endogenous to X50-7 cells. This result suggests that het sequences result in transactivation of the latent EBV. het DNA had homology with EBV sequences which are not normally contiguous on the physical map of the genome. het DNA was always accompanied by the presence of DNA of nonheterogenous HR-1. Thus, het DNA is a form of "defective" EBV DNA. However, the biological effect of this defective DNA is to enhance rather than to interfere with EBV replication. This is a novel property of defective virus.
Similar articles
- Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA.
Jenson HB, Rabson MS, Miller G. Jenson HB, et al. J Virol. 1986 May;58(2):475-86. doi: 10.1128/JVI.58.2.475-486.1986. J Virol. 1986. PMID: 3009861 Free PMC article. - P3HR-1 Epstein-Barr virus with heterogeneous DNA is an independent replicon maintained by cell-to-cell spread.
Miller G, Heston L, Countryman J. Miller G, et al. J Virol. 1985 Apr;54(1):45-52. doi: 10.1128/JVI.54.1.45-52.1985. J Virol. 1985. PMID: 2983118 Free PMC article. - Sequences of the Epstein-Barr Virus (EBV) large internal repeat form the center of a 16-kilobase-pair palindrome of EBV (P3HR-1) heterogeneous DNA.
Jenson HB, Farrell PJ, Miller G. Jenson HB, et al. J Virol. 1987 May;61(5):1495-506. doi: 10.1128/JVI.61.5.1495-1506.1987. J Virol. 1987. PMID: 3033277 Free PMC article. - Significance of the detection of Epstein-Barr virus DNA in lymph nodes in patients with Hodgkin's disease.
Knecht H, Joske DJ, Bachmann E, Sahli R, Odermatt BF. Knecht H, et al. Leuk Lymphoma. 1992 Nov;8(4-5):319-25. doi: 10.3109/10428199209051010. Leuk Lymphoma. 1992. PMID: 1337849 Review. - The biology and chemistry of Epstein-Barr virus.
Kieff E, Dambaugh T, Heller M, King W, Cheung A, van Santen V, Hummel M, Beisel C, Fennewald S, Hennessy K, Heineman T. Kieff E, et al. J Infect Dis. 1982 Oct;146(4):506-17. doi: 10.1093/infdis/146.4.506. J Infect Dis. 1982. PMID: 6288806 Review.
Cited by
- The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein.
Gruffat H, Manet E, Rigolet A, Sergeant A. Gruffat H, et al. Nucleic Acids Res. 1990 Dec 11;18(23):6835-43. doi: 10.1093/nar/18.23.6835. Nucleic Acids Res. 1990. PMID: 2175879 Free PMC article. - Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication.
Weigel R, Fischer DK, Heston L, Miller G. Weigel R, et al. J Virol. 1985 Jan;53(1):254-9. doi: 10.1128/JVI.53.1.254-259.1985. J Virol. 1985. PMID: 2981344 Free PMC article. - Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.
Chevallier-Greco A, Manet E, Chavrier P, Mosnier C, Daillie J, Sergeant A. Chevallier-Greco A, et al. EMBO J. 1986 Dec 1;5(12):3243-9. doi: 10.1002/j.1460-2075.1986.tb04635.x. EMBO J. 1986. PMID: 3028777 Free PMC article. - Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA.
Jenson HB, Rabson MS, Miller G. Jenson HB, et al. J Virol. 1986 May;58(2):475-86. doi: 10.1128/JVI.58.2.475-486.1986. J Virol. 1986. PMID: 3009861 Free PMC article. - Strain-specific transcription and translation of the BamHI Z area of Epstein-Barr Virus.
Seibl R, Motz M, Wolf H. Seibl R, et al. J Virol. 1986 Dec;60(3):902-9. doi: 10.1128/JVI.60.3.902-909.1986. J Virol. 1986. PMID: 3023679 Free PMC article.
References
- J Virol. 1967 Oct;1(5):1045-51 - PubMed
- J Virol. 1983 Jul;47(1):193-201 - PubMed
- Proc Natl Acad Sci U S A. 1974 Oct;71(10):4006-10 - PubMed
- Exp Cell Res. 1975 May;92(2):478-84 - PubMed
- J Virol. 1976 May;18(2):765-75 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources